Axxam announces the merger of its two German subsidiaries into Axxam GmbH
Axxam S.p.A., a privately-owned innovative Partner Research Organization (iPRO) announced the merger of its two subsidiaries located in Germany, Hit Discovery Constance GmbH (“HDC”) and IMAX Discovery GmbH (“IMAX”), into Axxam GmbH, located in Constance (Germany).
Under the new name the company will continue to offer its competences, resources and experience to its customers and partners supporting their research projects and facing together the new challenges with a joint and integrated approach.
Axxam GmbH is structured into two business units, namely Discovery Services Constance (“DSC”) and IMAX Discovery, deriving respectively from the two original companies. Dr. Thilo Enderle will continue in his role as Managing Director of Axxam GmbH and will lead the DSC business unit, while Dr. Marcel Winning will continue to lead the IMAX Discovery business unit.
Offering high-quality services including high-throughput screening (HTS) with plate optical detection (in 1536 and 384 well formats) and complementary technological readouts such as radiometric screening (SPA, flash-plate), the DSC business unit will cooperate in unison with the team in Milan responding to the increasing requests from the market for capacity and capabilities in early drug discovery research and specifically in facing challenging HTS projects.
The IMAX Discovery business unit will continue offering its clients and partners integrated solutions across the entire discovery process starting from flavor, fragrance and cosmetic target identification and validation up to the selection and development of new bioactive compounds by providing services, tools and integrated solutions tailored to the specific needs of its clients and partners.
Axxam SpA is a privately owned iPRO (innovative Partner Research Organization) and discovery company located at the Science Park OpenZone in Bresso (Milan, Italy). The Company is a leading provider of discovery services for the entire life sciences industry including pharmaceutical, crop protection, animal health, cosmetics and nutrition.